|
|
Regulation of the Microglial Neuroimmune Response by Long Non-Coding RNAs |
| 1R15AI156879-01A1 |
|
NIAID |
2022 |
|
|
I-Corps: Optical design and the development of high accuracy automated tick classification using computer vision |
| 3R43AI162425-01A1S1 |
|
NIAID |
2022 |
|
|
Developing Tolerization Therapies from a New T-cell Based Mouse Model of Neuromyelitis Optica |
| 5R01AI130548-05 |
|
NIAID |
2022 |
|
|
Transcriptional Checkpoints Of Autoimmune Encephalomyelitis |
| 5R01AI143676-03 |
|
NIAID |
2022 |
|
|
Molecular Mechanisms of IL-17-dependent autoimmune signaling |
| 5R01AI147383-03 |
|
NIAID |
2022 |
|
|
Validating Inhibitors of the Immunomodulatory Sphingosine 1-Phosphate Transporter SPNS2 |
| 5R01AI148178-03 |
|
NIAID |
2022 |
|
|
Building a two-way communication system: Bio-orthogonal superhydrophobic nanoparticles for controlled stimulation and real-time sensing of neurotransmitters |
| 1DP2GM150018-01 |
|
NIGMS |
2022 |
|
|
Dynamic interplay of eukaryotic translation and mRNA decay |
| 1K99GM140209-01A1 |
|
NIGMS |
2022 |
|
|
Isoform expression and post-transcriptional regulation of centrosomal plp mRNA |
| 1K99GM143517-01A1 |
|
NIGMS |
2022 |
|
|
In Silico Drug Design Targeting RNA Repeat Expansions |
| 1R15GM146199-01 |
|
NIGMS |
2022 |
